Erratum: Pharmacological properties of myrtacine® and its potential value in acne treatment (Planta Medica (2011) DOI: 10.1055/s-0030-1270955);Pharmacological properties of myrtacine® and its potential value in acne treatment

Planta Medica

Volumn 77, Issue 14, 2011, Pages 1582-1589

  Fiorini Puybaret, Christel ^a   Aries, Marie Françoise ^b   Fabre, Bernard ^a   Mamatas, Stelianos ^a   Luc, Joëlle ^b   Degouy, Arnaud ^b   Ambonati, Marco ^b   Mejean, Carine ^b   Poli, Florence ^c  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b Centre d'Immunologie Pierre Fabre   (France)

^c Cabinet de dermatologie   (France)

Author keywords

acne; antibacterial activity; inflammation; keratinocyte proliferation; Myrtaceae; myrtucommulones; Myrtus communis

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CALCIMYCIN; ERYTHROMYCIN; ETHANOLIC MYRTLE EXTRACT; MYRTACINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MINIMUM INHIBITORY CONCENTRATION; MYRTLE; PROPIONIBACTERIUM ACNES;

MYRTACEAE; MYRTUS COMMUNIS; P ACNES;

EID: 80053332226     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1271085     Document Type: Erratum

References (24)

1. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003 42 1287-1304 (Pubitemid 37491489)
2. Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Dermatol Venereol 2003 83 241-248 (Pubitemid 36920596)
3. AFSSAPS. [Recommendations of good clinical practice on the treatment of acne]. Ann Dermatol Venereol 2008 135 S137-S141
4. Strauss J S., Krowchuk D P., Leyden J J., Lucky A W., Shalita A R., Siegfried E C., Thiboutot D M., Van Voorhees A S., Beutner K A., Sieck C K., Bhushan R. American Academy of Dermatology/American Academy of Dermatology Association: guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007 56 651-663
5. Rotstein A, Lifshitz A, Kashman Y. Isolation and antibacterial activity of acylphloroglucinols from Myrtus communis. Antimicrob Agents Chemother 1974 6 539-542
6. Deriu A, Branca G, Molicotti P, Pintore G, Chessa M, Tirillini B, Paglietti B, Mura A, Sechi L A., Fadda G, Zanetti S. In vitro activity of essential oil of Myrtus communis L. against Helicobacter pylori. Int J Antimicrob Agents 2007 30 562-563 (Pubitemid 350051769)
7. Appendino G, Maxia L, Bettoni P, Locatelli M, Valdivia C, Ballero M, Stavri M, Gibbons S, Sterner O. Antibacterial galloylated alkylphloroglucinol glucosides from myrtle (Myrtus communis). J Nat Prod 2006 69 251-254
8. Sacchetti G, Muzzoli M, Statti G A., Conforti F, Bianchi A, Agrimonti C, Ballero M, Poli F. Intra-specific biodiversity of Italian myrtle (Myrtus communis) through chemical markers profile and biological activities of leaf methanolic extracts. Nat Prod Res 2007 21 167-179 (Pubitemid 47161247)
9. Rosa A, Deiana M, Casu V, Corona G, Appendino G, Bianchi F, Ballero M, Dessì M A. Antioxidant activity of oligomeric acylphloroglucinols from Myrtus communis L. Free Radic Res 2003 37 1013-1019 (Pubitemid 37229049)
10. Feisst C, Franke L, Appendino G, Werz O. Identification of molecular targets of the oligomeric nonprenylated acylphloroglucinols from Myrtus communis and their implication as anti-inflammatory compounds. J Pharmacol Exp Ther 2005 315 389-396 (Pubitemid 41380535)
11. Kashman Y, Rotstein A, Lifshitz A. The structure determination of two new acylphloroglucinols from Myrtus communis L. Tetrahedron 1974 30 991-997
12. Puybaret C, David B, Charveron M, Mamatas S. Myrtle extract, preparation method and use. EU patent EP1112079. 2001
13. Chene G, Dubourdeau M, Balard P, Escoubet-Lozach L, Orfila C, Berry A, Bernad J, Aries M F., Charveron M, Pipy B. n-3 and n-6 Polyunsaturated fatty acids induce the expression of COX-2 via PPAR gamma activation in human keratinocyte HaCaT cells. Biochim Biophys Acta 2007 1771 576-589 (Pubitemid 46680522)
14. Pollaud C, Krause S, Lepert J C., Orfila C, Seguelas M, Festal D, Decerprit J, Pipy B. Acetylated low density lipoprotein inhibits the incorporation of arachidonic acid in phospholipids with a concomitant increase of cholesterol arachidonate in rat peritoneal macrophages. Biochim Biophys Acta 1995 1259 211-219 (Pubitemid 26014977)
15. Salmon J A., Flower R J. Extraction and thin layer chromatography of arachidonic acid metabolites. Methods Enzymol 1982 86 478-493
16. Cunliffe W J., Holland D B., Clark S M., Stables G I. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000 142 1084-1091 (Pubitemid 30418292)
17. Plewig G, Fulton J E., Kligman A M. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch 1971 242 12-29
18. Popadic S, Ramic Z, Medenica L, Mostarica Stojkovic M, Trajkovi V, Popadic D. Antiproliferative effect of vitamin A and D analogues on adult human keratinocytes in vitro. Skin Pharmacol Physiol 2008 21 227-234 (Pubitemid 351989643)
19. Schroeder M, Zouboulis C C. All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes. Horm Metab Res 2007 39 136-140 (Pubitemid 46535571)
20. Leyden J J., McGinley K J., Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology 1998 196 55-58 (Pubitemid 28116040)
21. Strauss J S., Stranieri A M. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984 11 86-89 (Pubitemid 14084728)
22. Jeremy A H., Holland D B., Roberts S G., Thomson K F., Cunliffe W J. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003 121 20-27 (Pubitemid 36900450)
23. Rossi A, Di Paola R, Mazzon E, Genovese T, Caminiti R, Bramanti P, Pergola C, Koeberle A, Werz O, Sautebin L, Cuzzocrea S. Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. J Pharmacol Exp Ther 2009 329 76-86
24. Decker L C., Deuel D M., Sedlock D M. Role of lipids in augmenting the antibacterial activity of benzoyl peroxide against Propionibacterium acnes. Antimicrob Agents Chemother 1989 33 326-330 (Pubitemid 19071965)